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arkers, Mediators, or Both?*
on O. Lundberg, MD, PHD
tockholm, Sweden
he chemical reactivity of the free radical gas nitric oxide
NO) promotes rapid formation of other nitrogen oxides,
ost of which have been considered biologically inert.
herefore, the general view has been that NO acts in a
aracrine manner, exerting effects only in the close vicinity
f its site of production. This view is now rapidly changing
ecause it is becoming clear that many of NO’s reaction
roducts can convert back into bioactive NO. One example
hat has received great attention lately is the nitrite ion
NO2
), a product formed rapidly by oxidation of NO. It is
ow clear that several pathways exist for reduction of nitrite
ack to NO, and nitrite is in fact to be considered a major
torage pool of NO in blood and tissues (1–3). Another
xample is the formation of s-nitrosothiols, which may act
s stable carriers of NO.
See page 573
This new information adds a new dimension to measure-
ents of NO reaction products in health and disease.
nstead of being used merely as an index of historical NO
ormation, e.g., by the endothelium, they could actively be
laying a role in the pathophysiological processes of cardio-
ascular disease. In this issue of the Journal, Heiss et al. (4)
eport on measuring a variety of NO-related metabolites in
atients with endothelial dysfunction. The investigators
eport that the levels of nitrosylated compounds in plasma
re markedly reduced in the patients, and this decrease
orrelated to the severity of endothelial dysfunction as
ssessed by measurements of flow-mediated dilation of the
rachial artery. The investigators therefore suggest that
hese NO related species could be used as markers of
ndothelial function.
One of the NO-related metabolites, nitrite, has previ-
usly been reported to be a good marker of endothelial NO
roduction. Indeed, the investigators of the present article
ave estimated that as much as 70% of plasma nitrite
riginates from endothelial nitric oxide synthase (eNOS) in
he endothelium (5). Therefore, it was surprising that nitrite
as not significantly decreased in the present study. This
ay be related to the rather small sample size, but another
*Editorials published in the Journal of the American College of Cardiology do not
eccesarily represent the views of JACC or the American College of Cardiology.b
From the Department of Physiology and Pharmacology, Karolinska Institutet,
tockholm, Sweden.ikely explanation is the existents of other eNOS-
ndependent sources of plasma nitrite (see later text).
As the investigators point out, we do not know whether
he low nitroso compound levels are caused by a decreased
ndothelial NO formation or by an accelerated consumption
f these species. A major remaining question is whether the
ecreased nitroso compound levels are playing a part in the
athologic process, and this question could not be answered
n the present study. Such future studies could involve
re-treating animals with physiological levels of the indi-
idual nitroso compounds and then looking at protective
ffects, e.g., in ischemia reperfusion models, or even study of
hysiological effects of nitroso compound supplementation
o patients with low levels using a similar test array as the
ne used here. In fact, for one of the NO-related metabo-
ites, nitrite, this has been recently done and the results are
ntriguing, showing powerful protective effects of nitrite in
nimal models of ischemia-reperfusion injury (6–8). In
hese studies, it is suggested that nitrite acts via formation of
O, but there is also a possibility that nitrite can modulate
hysiological processes via other pathways, for example,
hrough direct s-nitrosylation of thiol-containing proteins.
Organic nitrates, for example nitroglycerine, are thought
o act via generation of NO in smooth muscle cells, but the
xact mechanism of action is still a matter of debate despite
ntense research for more than a century. Interestingly,
ecent studies now indicate that the nitrite ion is an obligate
ntermediate in the formation of NO. The further reduction
f nitrite to NO in the cell may follow one of several
athways (1). This again indicates that nitroso compounds
re not just inert waste products of NO metabolism but may
n fact be key players in biological processes.
An important next task will be to better define the source
f the various nitroso compounds in the circulation. Likely,
he levels are determined not only by endogenous NO from
O synthases but also by dietary factors, medications (e.g.,
he use of nitrovasodilators), and smoking habits (cigarette
moke contains huge amounts of nitrogen oxides). One of
he most intriguing possibilities of nitroso compounds in
elation to cardiovascular disease is the fact that the systemic
evels are greatly influenced by the diet (Fig. 1). As an
xample, vegetables (especially green leafy vegetables) con-
ain great amounts of nitrate (NO3
). Interestingly, inges-
ion of nitrate in an amount corresponding to about 300 g
pinach results in an almost four-fold increase in plasma
evels of nitrite (9). Conversion of nitrate to nitrite involves
nterosalivary circulation of nitrate and reduction to nitrite
n the oral cavity by commensal bacteria (10,11). Nitrite
hen enters the circulation after swallowing of saliva. The
btained systemic levels of nitrite are in the same range as
hose that have potent cardioprotective effects in animal
odels, in which nitrite was given systemically before
nduction of cardiac ischemia. This implies that systemic
evels of potentially cardioprotective nitroso compounds can
e influenced by the diet and offers a highly intriguing new
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February 7, 2006:580–1 Editorial Commentxplanation for the cardioprotective effects of a vegetarian
iet (10). Naturally, all of these assumptions need to be
ested in controlled clinical studies.
We now know from the interesting study by Heiss et al.
4) that plasma nitroso compound levels are decreased in
atients with endothelial dysfunction, a finding that could
e of diagnostic interest. The next critical step will be to
lucidate the true role of plasma nitroso compounds in the
athophysiology of cardiovascular disorders, which may very
ell expand the concept to also involve therapeutic oppor-
unities.
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